LC
Laura Chico Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
50
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
75%
Neutral
16.7%
Negative
8.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Residential Construction
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $30 |
7%
upside
| 1 | +22% |
0
%
| 13 Nov ‘25 20 days ago |
|
|
|
Outperform
Maintained
| $36 |
10%
downside
| 1 | +88% |
0
%
| 7 Nov ‘25 26 days ago |
|
|
|
Outperform
Maintained
| $32 |
38%
upside
| 1 | +31% |
0
%
| 7 Nov ‘25 26 days ago |
|
|
|
Outperform
Maintained
| $46 |
4%
upside
| 2 | +17% |
0
%
| 6 Nov ‘25 27 days ago |
|
|
|
Underperform
Maintained
| $77 |
59%
downside
| 1 | -162% |
0
%
| 6 Nov ‘25 27 days ago |
|
|
|
Outperform
Maintained
| $32 |
3%
upside
| 1 | +55% |
0
%
| 5 Nov ‘25 28 days ago |
|
|
|
Neutral
Downgraded
| $13 |
1%
upside
| 1 | +79% |
0
%
| 15 Oct ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $11 |
220%
upside
| 1 | +21% |
0
%
| 30 Sep ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $8 |
50%
upside
| 2 | +45% |
0
%
| 30 Sep ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| $48 | – | 1 | +55% |
0
%
| 9 Sep ‘25 2 months ago |
|